No products in the cart.

Chapter 06: Special Populations: Pregnant and Nursing Women

Pharmacology For the Primary Care Provider 4th Edition by Edmunds Mayhew

$2.99

Chapter 06: Special Populations: Pregnant and Nursing Women

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

MULTIPLE CHOICE

 

  1. A woman is in the 36th week of pregnancy. The nurse practitioner (NP) providing prenatal care learns that the woman has a history of two previous urinary tract infections during this pregnancy. A dipstick urinalysis in the office today is negative for leukocyte esterase and nitrites. The NP should:
a. prescribe a low-dose sulfonamide antibiotic for urinary tract infection prophylaxis.
b. order nitrofurantoin daily to minimize the patient’s risk of urinary tract infection late in her pregnancy.
c. encourage the patient to increase daily water intake and to wear only cotton underwear.
d. order a voiding cystourethrogram to rule out structural anomalies that may cause urinary tract infection.

 

 

ANS:  C

For women at risk for recurrent urinary tract infection while pregnant, prevention and treatment begin with nonpharmacologic therapy: forcing fluids and wearing cotton underpants. Sulfonamide antibiotics and nitrofurantoin are used for documented urinary tract infection during pregnancy, but not after the 36th week of gestation. A voiding cystourethrogram is not indicated and would expose the fetus to radiation.

 

DIF:    Cognitive Level: Applying (Application)                           REF:   77 – 78

 

  1. A woman tells a primary care NP that she is considering getting pregnant. During a health history, the NP learns that the patient has seasonal allergies, asthma, and epilepsy, all of which are well controlled with a second-generation antihistamine daily, an inhaled steroid daily with albuterol as needed, and an antiepileptic medication daily. The NP should counsel this patient to:
a. take her asthma medications only when she is having an acute exacerbation.
b. avoid using antihistamine medications during her first trimester of pregnancy.
c. discontinue her seizure medications at least 6 months before becoming pregnant.
d. use only oral corticosteroids and not inhaled steroids while pregnant for improved asthma control.

 

 

ANS:  B

Optimal treatment of asthma during pregnancy includes treatment of comorbid allergic rhinitis, which can trigger symptoms. Antihistamines are recommended after the first trimester, if possible. Asthma medications should be continued during pregnancy because poorly controlled asthma can be detrimental to the fetus; she should continue using her daily inhaled corticosteroid. Although discontinuing seizure medications is optimal, this must be done in conjunction with this woman’s neurologist because management of epilepsy during pregnancy is beyond the scope of the primary care provider. Oral corticosteroids have greater systemic side effects and greater effects on the fetus and should be used only as necessary.

 

DIF:    Cognitive Level: Applying (Application)                           REF:   78 – 79

 

  1. A woman has just learned she is pregnant and is in her 10th gestational week. The woman reports that she takes valproic sodium (Depakote) for a seizure disorder and has been seizure-free for several years. The NP should:
a. prescribe folic acid supplements.
b. change her antiepileptic drug to lamotrigine (Lamictal).
c. order prophylactic vitamin K to be given in the second trimester.
d. recommend that she discontinue taking the valproic sodium by 12 weeks.

 

 

ANS:  A

Maternal folic acid deficiency is induced by anticonvulsants, especially valproic acid, so folic acid supplements must be given. Although antiepileptic drugs can have consequences for the developing fetus, once a woman is pregnant, the benefit-risk ratio favors continued use of the woman’s current antiepileptic medication, so she should not discontinue the medication or change to lamotrigine. Vitamin K is recommended beginning at 36 weeks of gestation and for the newborn at birth to counter the possibility of hemorrhagic disease of the newborn.

 

DIF:    Cognitive Level: Applying (Application)                           REF:   79

 

Additional information

Add Review

Your email address will not be published. Required fields are marked *